Medicare will pay for Alzheimer's drug to patients enrolled in clinical trials
2022-01-12T13:40:17.878Z
The FDA approved the use of this drug last June, but asked the company to continue studying it to confirm its benefits. It is the first treatment approved in the United States to delay cognitive decline in Alzheimer's patients.